Program overview
Context
Indication: Breast Cancer
Mechanism: Unknown
Modality: Unknown
Sponsor: Dana-Farber Cancer Institute
Timeline Staleness Signal
Palbociclib
Palbociclib is flagged as timeline staleness signal because public records show timeline staleness, public results not found after completion. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 3/5
Timeline: 3/5
Recruitment burden: 1/5
Results availability: 3/5
Program risk: 5/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT02040857 | https://clinicaltrials.gov/study/NCT02806648 | https://clinicaltrials.gov/study/NCT03065621 | https://clinicaltrials.gov/study/NCT04318223
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT02040857 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | None |
| NCT02806648 | Low Signal (COMPLETED) | stale_update_signal | Completed No Results Found Signal | strict_eligibility_signal |
| NCT03065621 | Low Signal (COMPLETED) | stale_update_signal | Completed No Results Found Signal | strict_eligibility_signal |
| NCT04318223 | Unknown Status Signal (UNKNOWN) | stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal | Low Signal | strict_eligibility_signal |